The two-dose Pfizer COVID-19 vaccine is expected to get full-approval by the U.S. Food and Drug Administration on Monday, according to new reporting.
The New York Times cites those inside the regulatory agency, who say the FDA will grant full-approval this week. It was something that some inside the FDA hoped would have been complete by Friday.
However, last-minute paperwork and process were not completed, which resulted in the new date.
Pfizer currently has an emergency use authorization, along with Moderna and Johnson & Johnson’s vaccines for COVID-19. It’s unclear when Moderna and J&J might get full-approval.
The full-approval of Pfizer’s vaccine would come approximately one week after emergency use authorization of a third, booster dose for those that received their second dose eight months ago.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].